期刊文献+

两种基于恒定链活性片段载体在增强抗体分泌中作用的比较 被引量:5

Comparison of effect of two vector based on invariant chain segments on the increasing antibody production
下载PDF
导出
摘要 目的:比较基于恒定链片段的两种载体的免疫效果和作用机理。方法:分别构建了含新城疫病毒抗原表位F306和Ii不同片段的三个嵌合体(Ii-key/F306、Ii-key/F306/ND(两个氨基酸残基)和用抗原表位取代Ii-CLIP的Ii/F306),经纯化后的融合蛋白免疫小鼠,并用ELISA检测其抗体效价。同时嵌合体与Mhc共转染COS7细胞,观察两者的细胞定位与结合。结果:Ii-key/F306免疫组比单独F306抗原肽免疫组的抗体效价提高2倍,Ii-key/F306/ND免疫组增至4倍,而Ii-F306免疫组只增强2.5倍。在与Mhc共转染的COS7细胞和免疫共沉淀中,Ii-key/F306和Ii-key/F306/ND既没有与MHCⅡ分子的膜共定位作用,也不能与后者结合;而Ii-F306却能与MHCⅡ分子在浆膜共定位,并与后者结合。结论:这些结果表明,嵌合体都具有增强免疫效果的作用,并提示Ii片段促进了抗原肽与MHCⅡ分子结合。 Objective:To compare the effects of two vectors based on invariant chain(Ii) segments on the immune response.Methods: Three hybrids containing NDV epitope F306 and Ii segments,Ii-key/F306,Ii-key/F306/ND(two residues) and Ii/F306 in which CLIP was replaced by epitope F306,were reconstructed respectively.BALB/c mice were immunized with the purified fusion proteins and the antibody titers were detected with ELISA respectively.Meanwhile the hybrids and Mhc were co-transfected in COS7 cells to observe their location and binding.Results: The groups immunized with Ii-key/F306 or Ii-key/F306/DN had two-fold or four-fold higher antibody titers than that immunized with F306 alone respectively,but the group immunezed with Ii-F306 enhanced only two and a half-fold higher antibody titers.In the co-transfected COS7 cells,neither Ii-key/F306 nor Ii-key/F306/DN could co-locate on the plasma membrane or bind with MHC class Ⅱ molecule.However,Ii-F306 could co-locate and bind with MHC class Ⅱ molecule.Conclusion: These results showed that these hybrids could increase the immune response and suggested that Ii segments improved binding of the epitope to MHC class Ⅱ molecule.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2012年第8期728-732,共5页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(No.31172306)
关键词 恒定链 抗体 共定位 MHCⅡ类分子 Invariant chain(Ii) Antibody Co-location MHC class Ⅱ molecule
  • 相关文献

参考文献20

  • 1Lindner R. Transient surface delivery of invariant chain-MHC Ⅱ com- plexes via endosomes : a quantitative study [ J]. Traffic, 2002 ; 3 : 133-146.
  • 2Sandrais C, Spehner D, de la Salle H et al. Intracellular pathway for the generation of functional MHC class Ⅱ peptide complexes in imma- ture human dendritic ceils [ J]. J Immunol, 1998; 160:2597-2607.
  • 3Romaguoli P, Germain R N. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class Ⅱ folding, transport, and peptide occupancy [J]. J Exp Med, 1994; 180:1107-1113.
  • 4Jasanoff A, Wagner G, Wiley D C. Structure of a trimeric domain of the MHC class Ⅱ-associated chaperonin and targeting protein li [ J ]. EMBO J, 1998 ; 17:6812-6818.
  • 5Stumptner P, Benaroch P. Interaction of MHC class Ⅱ molecules with the invariant chain : role of the invariant chain ( 81-90 ) region [ J ]. EMBO J, 1997 ; 16:5807-5818.
  • 6Busch R, Rinderknecht C H, Roh Set al. Achieving stability through editing and chaperoning: regulation of MHC class Ⅱ peptide binding and expression I J]. Immunol Rev, 2005; 207:242-260.
  • 7Roche P A, Cresswell P. Proteolysis of the class Ⅱ-associated invari- ant chain generates a peptide binding site in intracellular HLA-DRmolecules [ J ]. J Immunol, 2011 ; 187 : 1076-1080.
  • 8Gunther S, Schlundt A, Sticht Jet al. Bidirectional binding of invari- ant chain peptides to an MHC class Ⅱ molecule [ J]. Proc Nail Acad Sci USA, 2010; 107:22219-22224.
  • 9Mikkelsen M, Hoist P J, Bukh Jet al. Enhanced and sustained CD8^ + T cell responses with an adenoviral vector-based hepatitis C vi- rus vaccine encoding NS3 linked to the MHC class Ⅱ chaperone pro- tein invariant chain [J]. J Immunol, 2011; 186:2355-2364.
  • 10Kim D, Hoory T, Monie A et al. Enhancement of DNA vaccine po- tency through coadministration of CIITA DNA with DNA vaccines via gene gun [J]. J Immunol, 2008; 180:7019-7027.

二级参考文献15

  • 1韦三华,尹文,雷迎峰,胡兴斌,杨敬,吕欣,孙梦宁,徐志凯.稳定表达丙型肝炎病毒复合多表位基因P815细胞克隆的建立[J].第四军医大学学报,2006,27(1):38-41. 被引量:4
  • 2Bilsborough J, Pel A V, Uyttenhove C, Boon T and van den Eynde B J. Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815 (J). Journal of Immunology, 1999, 162:3534-3540.
  • 3Blanton J R J, Bidwell C A, Sanders D A, Sharkey C M, McFarland D C, Gerrard D E and Grant A L. Plasmid transfection and retroviral transduction of porcine muscle cells for cell-mediated gene transfer (J). Journal of Animal Science, 2000, 78 (4): 908-918.
  • 4de Leeuw O S, Hartog L, Koch G and Peeters B P. Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: Non-virulent cleavage site mutants revert to virulence after one passage in chicken brain (J). The Journal of General Virology, 2003, 84:475-484.
  • 5Pan G, Shawer M, Oie S and Lu D R.In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system (J). Pharmaceutical Research, 2003, 20 (5): 738-744.
  • 6Peeters B P, de Leeuw O S, Koch G and Gielkens A L. Rescue of Newcastle disease virus from cloned cDNA: Evidence that cleavability of the fusion protein is a major determinant for virulence (J). Journal of Virology, 1999, 73:5001-5009.
  • 7Sakaguchi M, Nakamura H, Sonoda K, Hamada F and Hirai K.Protection of chickens fi'om Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus (J). Vaccine, 1996, 14:747-752.
  • 8Sandor M, Mehta S, Harris J, Thanos C, Weston P, Marshall J and Mathiowitz E. Transfection of HEK cells via DNA-loaded PLGA and P (FASA) nanosphers (J). Journal of Drug Targeting, 2002, 10 (6): 497-506.
  • 9Yang C Y, Shieh H K, Lin Y L and Chang P C. Newcastle disease virus isolated from recent outbreaks in Taiwan phylogenetically related to viruses (GenotypeVII) from recent outbreaks in Westrem Europe (J). Avian Disease, 1999, 43:125-130.
  • 10BREMNES B,RODE M,GEDDEDAHL M,et al.The MHC classⅡ-associated chicken invariant chain shares functional properties with its mammalian homloges[J].Exp Cell Res,2000,259(2):360-369.

共引文献1

同被引文献96

  • 1于在江,马学恩,周建华.切胶纯化表达蛋白包涵体的可行性分析[J].生物技术,2007,17(3):46-48. 被引量:38
  • 2Arden B, Clark SP, Kabelitz D, et al. Human T-cell receptor varia / ble gene segment families. Immunogenetics, 1995,42 ( 6 ) : 455t / 500.
  • 3Schwarz BA, Bhandoola A. Trafficking from the bone manw to the thymus: a prerequisite for thy'mopoiesis. Immunol Rev,2006,209: 47 -57.
  • 4Baldwin TA, Hogquist KA, Jameson SC. The fourth way? Harness- ing aggressive tendencies in the thymus. J Immunol, 2004, 173 ( 11 ) :6515-6520.
  • 5Watanabe N, Wang YH, Lee HK, et al. Hassa11' s corpuscles in- struct dendritic cells to induce CIM + CD25 + regulatory T cel|s in human thymus. Nature ,2005,436 (7054) : 1181-1185.
  • 6Hanabuchi S, Ito T, Park WR, et al. Thymic stromal lymphopoietin- activated plasmacytoid dndritic cells induce the generation of FOXP3 + regulatory T cells in human thymus. J Immunol,2010, 184(6) :2999-3007.
  • 7Wang RF. Identification of MHC class II-restricted tumor antigens recognized by CIM + T cells. Methods ,2003,29 (3) :227-235.
  • 8Pieters J. MHC class II-restricted antigen processing and presenta- tion. Adv Immuno1,2000,75 : 159-205.
  • 9Rocha N, Neefjes J. MHC class II molecules on the move for suc- cessful antigen presentation. EMBO J,2008,27 (1) :1-5.
  • 10Wang RF. Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens. Immunol Rev,2002,188:65-$0.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部